Variations on the Fludarabine, Cyclophosphamide, and Rituximab Combination in Chronic Lymphocytic Leukemia Therapy: What Have We Learned?

被引：8

作者：

Ahmadi, Tahamtan ^{[1
]}

Schuster, Stephen J. ^{[1
]}

机构：

[1] Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA 19104 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 04期

关键词：

D O I：

10.1200/JCO.2008.18.8698

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：479 / 480

页数：2

共 4 条

[1] Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia [J].

Foon, Kenneth A. ;

Boyiadzis, Michael ;

Land, Stephanie R. ;

Marks, Stanley ;

Raptis, Anastasios ;

Pietragallo, Louis ;

Meisner, Dennis ;

Laman, Andrew ;

Sulecki, Mathew ;

Butchko, Allyson ;

Schaefer, Patricia ;

Lenzer, Diana ;

Tarhini, Ahmad .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) :498-503

[2] Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses [J].

Lamanna, Nicole ;

Jurcic, Joseph G. ;

Noy, Ariela ;

Maslak, Peter ;

Gencarelli, Alison N. ;

Panageas, Katherine S. ;

Heaney, Mark L. ;

Brentjens, Renier J. ;

Golde, David W. ;

Scheinberg, David A. ;

Zelenetz, Andrew D. ;

Weiss, Mark A. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) :491-497

[3] Further progress in CLL therapy [J].

Montserrat, Emili .

BLOOD, 2008, 112 (04) :924-925

[4] Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia [J].

Tam, Constantine S. ;

O'Brien, Susan ;

Wierda, William ;

Kantarjian, Hagop ;

Wen, Sijin ;

Do, Kim-Anh ;

Thomas, Deborah A. ;

Cortes, Jorge ;

Lerner, Susan ;

Keating, Michael J. .

BLOOD, 2008, 112 (04) :975-980

← 1 →